These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7510002)

  • 1. Rapid inactivation of endothelin-1 by a carboxypeptidase-like enzyme purified from rat kidney.
    Jeng AY; Deng Y
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S69-72. PubMed ID: 7510002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of an endothelin degradation enzyme from rat kidney.
    Deng AY; Martin LL; Balwierczak JL; Jeng AY
    J Biochem; 1994 Jan; 115(1):120-5. PubMed ID: 8188617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble protease identified from rat kidney degrades endothelin-1 but not proendothelin-1.
    Deng Y; Martin LL; DelGrande D; Jeng AY
    J Biochem; 1992 Jul; 112(1):168-72. PubMed ID: 1429507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of endothelin I by deamidase (lysosomal protective protein).
    Jackman HL; Morris PW; Deddish PA; Skidgel RA; Erdös EG
    J Biol Chem; 1992 Feb; 267(5):2872-5. PubMed ID: 1737744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble endothelin degradation enzyme activities in various rat tissues.
    Deng Y; Jeng AY
    Biochem Cell Biol; 1992 Dec; 70(12):1385-9. PubMed ID: 1299274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid degradation of endothelin-1 by an enzyme released by the rat isolated perfused mesentery.
    Pérez-Vizcaíno F; Cooper AC; Corder R; Fournier A; Warner TD
    Br J Pharmacol; 1995 Feb; 114(4):867-71. PubMed ID: 7773548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in immunoreactivity and vasoactivity of endothelin-1 after exposure to oxygen.
    Balwierczak JL; Hopkins MF; Savage P; Martin LL; Jeng AY
    Biochem Int; 1992 Sep; 27(6):1111-7. PubMed ID: 1445378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional role of endothelin ETA and ETB receptors in venous and arterial smooth muscle.
    Lodge NJ; Zhang R; Halaka NN; Moreland S
    Eur J Pharmacol; 1995 Dec; 287(3):279-85. PubMed ID: 8991802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of endothelin-1 by an enzyme of the vascular endothelial cells.
    Jackman HL; Morris PW; Rabito SF; Johansson GB; Skidgel RA; Erdös EG
    Hypertension; 1993 Jun; 21(6 Pt 2):925-8. PubMed ID: 8505102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.
    Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY
    Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors.
    Maggi CA; Giuliani S; Patacchini R; Santicioli P; Rovero P; Giachetti A; Meli A
    Eur J Pharmacol; 1989 Jul; 166(1):121-2. PubMed ID: 2553427
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and partial purification of a thiol endothelin-converting enzyme from porcine aortic endothelial cells.
    Deng Y; Savage P; Shetty SS; Martin LL; Jeng AY
    J Biochem; 1992 Mar; 111(3):346-51. PubMed ID: 1587796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-converting enzyme and its in vitro and in vivo inhibition.
    Yano M; Okada K; Takada J; Hioki Y; Matsuyama K; Fukuroda T; Noguchi K; Nishikibe M; Ikemoto F
    J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S26-8. PubMed ID: 1725349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
    Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
    Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective protein as an endogenous endothelin degradation enzyme in human tissues.
    Itoh K; Kase R; Shimmoto M; Satake A; Sakuraba H; Suzuki Y
    J Biol Chem; 1995 Jan; 270(2):515-8. PubMed ID: 7822272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin ETA and ETB receptors mediate vascular smooth-muscle contraction.
    White DG; Cannon TR; Garratt H; Mundin JW; Sumner MJ; Watts IS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S144-8. PubMed ID: 7509927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacology of rat and porcine endothelin in rat aorta and pulmonary artery.
    Rodman DM; McMurtry IF; Peach JL; O'Brien RF
    Eur J Pharmacol; 1989 Jun; 165(2-3):297-300. PubMed ID: 2673799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1, but not sarafotoxin s6b, induces cross-desensitization of rat aorta contraction.
    Auguet M; Delaflotte S; Guillon JM; Roubert P; Chabrier PE; Braquet P
    Eur J Pharmacol; 1990 Oct; 187(2):293-4. PubMed ID: 2272365
    [No Abstract]   [Full Text] [Related]  

  • 20. [The role of endothelin in the contractile reactions of vascular smooth muscles in hypertensive rats].
    Tkachenko MM
    Fiziol Zh (1994); 1997; 43(5-6):89-95. PubMed ID: 9463014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.